InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: tiggerifficm4 post# 25905

Saturday, 10/10/2020 3:39:26 PM

Saturday, October 10, 2020 3:39:26 PM

Post# of 44690
Aviptadil and some others, certainly don't have the past of Gilead/Rem, as it was developed in Wuhan during research. There is a direct path from there to the rest of the world. Bat soup?
While looking into Regn-cov2 I keep finding talk like this. No firm explanations with round-about denials of the use of aborted fetuses' stem cells.
We can guess that R-cov2 will be extremely more expensive than Rem. Both seem hard to manufacture with questionable ingredients. Both have ethics issues. Both have limited access and incomplete Trials... Dexa*.?.
Average Covid infected patients don't receive care as early as Mr. T did. Most would only get one experimental drug at a time. Most insurance companies balk at even ONE experimental drug and then patients need to have strong Doctor support to just JOIN a Trial, then submit to their Ins-co. All this takes TIME Covid patients can't waste.
Apparently the early attacking Covid is working better than reactionary Treatments...Just some opinions...

https://www.usatoday.com/story/news/factcheck/2020/10/08/fact-check-trumps-antibody-therapy-not-made-fetal-stem-cells/5901542002/